Vaxart (VXRT) announced the appointment of Jeroen Grasman as its CFO, effective May 19. Grasman succeeds Phillip Lee, who is resigning from his position as CFO for personal reasons. To ensure a smooth transition, Lee will remain with the company as a non-executive employee through June 1. Grasman most recently served as CFO at AltruBio.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VXRT:
- Options Volatility and Implied Earnings Moves Today, May 13, 2025
- Vaxart Proposes Reverse Stock Split to Avoid Delisting
- Vaxart addresses FAQs about reverse stock split proposal
- Options Volatility and Implied Earnings Moves This Week, May 12 – May 15, 2025
- VXRT Earnings this Week: How Will it Perform?